INTERNATIONAL PATENT: YICHANG HUMANWELL PHARMACEUTICAL CO., LTD, 宜昌人福药业有限责任公司 FILES APPLICATION FOR "NON-SELECTIVE CATION CHANNEL TRPA1 ANTAGONIST AND USE THEREOF"

GENEVA, Aug. 17 -- YICHANG HUMANWELL PHARMACEUTICAL CO., LTD (No.19, Dalian Road, Yichang Development ZoneYichang, Hubei 443005), 宜昌人福药业有限责任公司 (中国湖北省宜昌市宜昌开发区大连路19号) filed a patent application (PCT/CN2025/076019) for "NON-SELECTIVE CATION CHANNEL TRPA1 ANTAGONIST AND USE THEREOF" on Feb 06, 2025. With publication no. WO/2025/167992, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World...